Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Impairment of visuospatial/visuoconstructional skills in multiple sclerosis patients: the correlation with regional lesion load and subcortical atrophy.
Sequence of Molecular Events during the Maturation of the Developing Mouse Prefrontal Cortex.
Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
Chemokine receptor expression by inflammatory T cells in EAE.
B-61Impact of Sleep Quality, Depression, Daytime Sleepiness, and Fatigue on Cognition in Multiple Sclerosis.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Remyelinating strategies in multiple sclerosis.
Common gut microbe could help prevent development of multiple sclerosis.
Pharmacological treatments for fatigue associated with palliative care.
Charcot-marie-tooth disease type 1x in women: Electrodiagnostic findings.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Validity of The Timed Up and Go as A Measure of Functional Mobility in Persons with Multiple Sclerosis.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.

Pages